Satsuma Pharmaceuticals Aktie 49628185 / US80405P1075
0.98
EUR
0.05
EUR
4.84%
19.05.2023
L&S
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
Satsuma Pharmaceuticals Dividenden Kalender
| Datum | Name | Rendite * | Dividende | Währung |
|---|---|---|---|---|
| 2022 | Satsuma Pharmaceuticals Inc Registered Shs | 0.00 | 0.00 | USD |
| 2021 | Satsuma Pharmaceuticals Inc Registered Shs | 0.00 | 0.00 | USD |
| 2020 | Satsuma Pharmaceuticals Inc Registered Shs | 0.00 | 0.00 | USD |
| 2019 | Satsuma Pharmaceuticals Inc Registered Shs | 0.00 | 0.00 | USD |
| 2018 | Satsuma Pharmaceuticals Inc Registered Shs | - | - | USD |
| 2017 | Satsuma Pharmaceuticals Inc Registered Shs | - | - | USD |
Zu diesem Datensatz liegen uns leider keine Daten vor.
Satsuma Pharmaceuticals Inc Registered Shs Termine
| Unternehmen | Event | Datum |
|---|
Satsuma Pharmaceuticals Inc Registered Shs vergangene Termine
| Terminart | Info | Datum |
|---|
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| BML Capital Management LLC | 19.43 |
| RA Capital Management LP | 17.84 |
| NEA Management Co. | 6.92 |
| NEA Management Co. LLC | 4.99 |
| Vanguard Group, Inc. (Subfiler) | 2.75 |
| Driehaus Capital Management LLC | 2.46 |
| Vanguard Total Stock Market ETF | 1.58 |
| Geode Capital Management LLC | 1.25 |
| Vanguard Extended Market Index Fund | 1.02 |
| Lion Point Capital LP | 0.96 |
| Two Sigma Investments LP | 0.90 |
| Two Sigma Advisers LP | 0.83 |
| Acadian Asset Management LLC | 0.83 |
| Dimensional Fund Advisors LP (13F Subfiler) | 0.70 |
| Pivotal Bioventure Partners Investment Advisor LLC | 0.54 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 0 | 0 | 17 | 19 | 21 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Bilanz (in Mio. USD) - Aktiva
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 2 | 5 | 115 | 74 | 100 |
| Summe Anlagevermögen | 0 | 1 | 12 | 7 | 10 |
| Summe Aktiva | 2 | 6 | 126 | 81 | 110 |
Bilanz (in Mio. USD) - Passiva
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 7 | 19 | 11 | 9 | 8 |
| Summe Eigenkapital | -5 | -12 | 115 | 72 | 101 |
| Summe Passiva | 2 | 6 | 126 | 81 | 110 |